In patients with vitiligo, activation of IRE1α-XBP1 signalling increases CD8+ T-cell recruitment by upregulating CXCL16 expression, thereby leading to melanocyte-specific autoimmune responses and depigmentation of the skin [165]. Here, XBP1 is linked to vitiligo.